News & Updates

Quercetin augments therapeutic benefit of antivirals for COVID-19
Quercetin augments therapeutic benefit of antivirals for COVID-19
03 Feb 2022 byAudrey Abella

In patients hospitalized for severe COVID-19, adding the plant flavonoid quercetin to the antiviral drugs remdesivir or favipiravir reduced hospitalization period and levels of inflammatory markers related to the pathogenesis of SARS-CoV-2, thus preventing the progression of the disease into its critical phase, suggests an open-label study from Iran.

Quercetin augments therapeutic benefit of antivirals for COVID-19
03 Feb 2022
SG’s cramped migrant worker dorms prone to COVID-19 outbreaks
SG’s cramped migrant worker dorms prone to COVID-19 outbreaks
03 Feb 2022
Reaction patterns may aid in diagnosis of COVID-19 vaccine-related cutaneous side effects
Reaction patterns may aid in diagnosis of COVID-19 vaccine-related cutaneous side effects
02 Feb 2022 byStephen Padilla

A registry-based study has recently shown diverse COVID-19 vaccine-associated dermatologic reactions, including papulovesicular, pityriasis rosea-like, and papulosquamous eruptions classified as vaccine-related eruption of papules and plaques (V-REPP).

Reaction patterns may aid in diagnosis of COVID-19 vaccine-related cutaneous side effects
02 Feb 2022
Certain groups of minority women more susceptible to vaginal infections
Certain groups of minority women more susceptible to vaginal infections
29 Jan 2022